Clinical experience with vaccines produced in the human diploid cell line WI-38.
作者信息
Andzaparidze O G
出版信息
Natl Cancer Inst Monogr. 1968 Dec;29:477-84.
PMID:4976367
Abstract
摘要
相似文献
1
Clinical experience with vaccines produced in the human diploid cell line WI-38.在人二倍体细胞系WI-38中生产的疫苗的临床经验。
Natl Cancer Inst Monogr. 1968 Dec;29:477-84.
2
Vaccines produced in diploid cell lines.在二倍体细胞系中生产的疫苗。
Natl Cancer Inst Monogr. 1968 Dec;29:485-93.
3
Vaccines produced in heteroploid cell lines--discussion.异倍体细胞系生产的疫苗——讨论
Natl Cancer Inst Monogr. 1968 Dec;29:471-2.
4
Karyologic characteristics of the WI-38 diploid cell system--general comments.WI-38二倍体细胞系的核型特征——一般性评论
Natl Cancer Inst Monogr. 1968 Dec;29:97-104.
5
Monitoring vaccines for human oncogenicity.
Natl Cancer Inst Monogr. 1968 Dec;29:453-5.
6
Characteristics of primary cultures and diploid cells--technology of production.
Natl Cancer Inst Monogr. 1968 Dec;29:21-31.
7
Cell cultures for virus vaccine production. General conclusions from the conference.用于病毒疫苗生产的细胞培养。会议总结
Natl Cancer Inst Monogr. 1968 Dec;29:583-4.
8
Virus-associated gain and loss of proliferative and neoplastic properties of normal and virus-transformed diploid cell lines.病毒相关的正常和病毒转化的二倍体细胞系增殖及肿瘤特性的获得与丧失
Natl Cancer Inst Monogr. 1968 Dec;29:241-68.
9
Technology of production of primary and diploid cell cultures.原代细胞培养和二倍体细胞培养的生产技术。
Natl Cancer Inst Monogr. 1968 Dec;29:33-4.
10
Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.RA 27-3风疹病毒在WI-38人二倍体细胞中的减毒
Am J Dis Child. 1969 Aug;118(2):178-85. doi: 10.1001/archpedi.1969.02100040180004.
Zotero 插件